Live Feeds
● TRACKER Updated 20d ago · 8 sources tracked

McKesson strikes $2.25 billion Precision Medicine deal in clinical research bets

McKesson has agreed to buy Precision Medicine Group for $2.25 billion, aiming to enhance its oncology and clinical research services. The acquisition is part of McKesson's efforts to bolster its portfolio and drive sustainable growth. This deal comes amid McKesson's reorganization and layoffs.

🎙️

Listen to Live Briefing

Real-time synthesized voice briefing · Live Feeds Desk

⏱ ~2 min
Speed:
RSS Source map (8)
⚡ Key Developments & Real-Time Context
Text size:
  • ✓ McKesson is acquiring Precision Medicine Group for $2.25 billion
  • ✓ The acquisition aims to enhance McKesson's oncology and clinical research services
  • ✓ McKesson is undergoing reorganization and layoffs
🛡️ Source Corroboration: 8 independent reporting domains (90% confidence) ⏱ Read time: ~1 min

What changed

McKesson announced its agreement to acquire Precision Medicine Group, marking a significant expansion in its clinical research services.

Live updates

  1. McKesson acquires Precision Medicine Group for $2.25 billion

    McKesson has agreed to buy Precision Medicine Group for $2.25 billion, aiming to enhance its oncology and clinical research services. The acquisition is part of McKesson's efforts to bolster its portfolio and drive sustainable growth. This deal comes amid McKesson's reorganization and layoffs.

    Why it matters

    The acquisition is a strategic move by McKesson to expand its presence in the precision medicine market. Precision Medicine Group provides clinical research services, including site management and research support. This deal is expected to drive growth in McKesson's oncology and clinical research services.

    What is confirmed

    • McKesson is acquiring Precision Medicine Group for $2.25 billion
    • The acquisition aims to enhance McKesson's oncology and clinical research services
    • McKesson is undergoing reorganization and layoffs

    What to watch next

    • Completion of the acquisition
    • Integration of Precision Medicine Group into McKesson's operations
    • Impact on McKesson's future financial performance
    Sources used for this update (8)
    1. Reuters — McKesson strikes $2.25 billion Precision Medicine deal in clinical research bets
    2. The Business Journals — McKesson opens wallet for $2.25 billion amid reorganization, layoffs
    3. Fierce Pharma — McKesson strikes $2.25B deal to snap up Precision Medicine Group
    4. Business Wire — McKesson Signs Agreement to Acquire Precision Medicine Group, LLC
    5. Axios — McKesson to buy Precision Medicine Group for $2.25B
    6. thedeal.com — Deal Diary: Centerview, Legal Trio Work Precision Medicine Sale
    7. GuruFocus — MCK Looks 8.9% Overvalued on GF Value™ After $2.25B Precision Me
    8. pharma.economictimes.indiatimes.com — McKesson strikes $2.25 billion Precision Medicine deal in clinical research bets
    confidence 90%
📊

Community Sentiment: How do you assess this situation?

Voice your perspective · Real-time aggregated sentiment from the Live Feeds community